Cti Biopharma Corp Revenue per Employee (CTIC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cti Biopharma Corp   (NASDAQ: CTIC)
 

Cti Biopharma 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 950.81% in the first quarter 2023, year on year to cumulative value of $76 million, Cti Biopharma 's revenue per employee grew on a trailing twelve months basis to $ 947,113, this marks a new company high.
Within the Healthcare sector Employees of 96 other companies have achieved higher revenue per employee. While Cti Biopharma 's total ranking has deteriorated compared to the previous quarter from 0 to 982. Cti Biopharma has 80 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTIC Revenue per Employee (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Revenue Change 950.81 % - - - -
Sales per Employee (TTM) $ 947,113 674,350 410,813 182,800 28,688
CTIC's Total Ranking # 982 # 0 # 0 # 0 # 0
Seq. Revenue Change 14.39 % 15.58 % 47.95 % 437.21 % -

CTIC Company Profile >> Back to CTIC Efficiency Comparisons >> Compare CTIC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 56
Healthcare Sector # 97
Overall Market # 982

Revenue per Employee Statistics
High Average Low
$ 947,113 $ 423,568 $ 57,813
(Mar 31 2023)   (Dec 31 2019)



Financial Statements
Cti Biopharma 's Revenue MRQ $ 24 Millions Visit CTIC's Income Statement
Cti Biopharma 's Revenues TTM $ 76 Millions Visit CTIC's aggregate revenue growth
What are CTIC's Sales? Visit CTIC's Sales by Segment




Other Ratios
Cti Biopharma 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CTIC's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CTIC's Competitors
Revenue per Employee for CTIC's Suppliers
Revenue per Employee for CTIC's Customers

You may also want to know
CTIC's Sales Growth Rates CTIC's Pe Price to earnings ratio CTIC's Receivables Turnover Ratio CTIC's Stock Quote
CTIC's Net Income Growth Rates CTIC's Ps Price to Sales ratio CTIC's Sales per Employee CTIC's Asset Turnover Ratio
CTIC's Net Margin CTIC's Pb Price to Book ratio CTIC's Financial Strength Ratios CTIC's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:58+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2023Number of Employees Mar 31 2023
Maravai Lifesciences Holdings Inc   1,649,960.92 $ 717.733  Million 435 
Harmony Biosciences Holdings inc   1,609,788.40 $ 471.668  Million 293 
Gilead Sciences Inc   1,590,764.71 $ 27,043.000  Million 17,000 
Ispecimen inc   1,547,691.43 $ 10.834  Million 7 
Intra cellular Therapies Inc   1,537,742.57 $ 310.624  Million 202 
Exelixis Inc   1,450,627.72 $ 1,663.870  Million 1,147 
United Therapeutics Corporation  1,415,214.29 $ 1,981.300  Million 1,400 
Bristol myers Squibb Company  1,410,707.69 $ 45,848.000  Million 32,500 
Nektar Therapeutics  1,409,952.38 $ 88.827  Million 63 
Collegium Pharmaceutical Inc   1,409,300.24 $ 596.134  Million 423 
Catalyst Pharmaceuticals Inc   1,409,230.77 $ 256.480  Million 182 
Akebia Therapeutics Inc   1,396,453.61 $ 270.912  Million 194 
Voyager Therapeutics Inc   1,352,687.94 $ 190.729  Million 141 
Biogen Inc   1,347,280.00 $ 10,104.600  Million 7,500 
Keenova Therapeutics Plc  1,338,625.00 $ 2,141.800  Million 1,600 
Paragon 28 inc   1,333,666.67 $ 192.048  Million 144 
Puma Biotechnology Inc   1,313,240.22 $ 235.070  Million 179 
Jazz Pharmaceuticals Plc  1,293,586.51 $ 3,738.465  Million 2,890 
Coherus Oncology inc   1,247,367.35 $ 183.363  Million 147 
Pfizer Inc  1,239,346.67 $ 92,951.000  Million 75,000 
Scilex Holding Company  1,229,529.41 $ 41.804  Million 34 
Alector Inc   1,220,310.68 $ 125.692  Million 103 
Incyte Corporation  1,220,138.19 $ 3,470.073  Million 2,844 
Vir Biotechnology Inc   1,216,062.67 $ 446.295  Million 367 
Cidara Therapeutics Inc   1,209,362.32 $ 83.446  Million 69 
Thorne Healthtech Inc   1,184,658.13 $ 239.301  Million 202 
Agenus Inc  1,172,654.32 $ 94.985  Million 81 
Imagenebio Inc   1,169,800.00 $ 17.547  Million 15 
Sarepta Therapeutics Inc   1,168,482.63 $ 975.683  Million 835 
Privia Health Group Inc   1,165,689.23 $ 1,429.135  Million 1,226 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.